Company / EPS (Diluted)
Zivo Bioscience, Inc. EPS (Diluted) History
FY2013-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$4.60
FY2024
5-year range
-$4.60 / -$0.04
FY2020-FY2024
Trend
-
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed -11400% YoY in FY2024, a notable deviation from the 5-year average annual change of -2323%.
Based on SEC 10-K filings.
-4.60 in FY2024.
Declined from $-0.09 to $-4.60 over the past 5 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Peak eps (diluted) was recorded in FY2013.
Company context
Key Data Points
- Altman Z-Score -96.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$4.60 | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | -$0.04 | +55.6% |
| FY2019 | -$0.09 | -125.0% |
| FY2016 | -$0.04 | - |
| FY2015 | - | - |
| FY2014 | -$0.09 | -200.0% |
| FY2013 | -$0.03 | +0.0% |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026